Insights

Market Expansion Valeritas has established a strong presence in the US and EU markets with its flagship V-Go device, creating opportunities to expand into additional countries and underserved regions to increase market share and address the global diabetes management needs.

Product Differentiation The V-Go wearable insulin delivery device offers a simplified and discreet alternative to multiple daily injections, presenting a compelling value proposition for healthcare providers and patients seeking convenient and efficient diabetes management solutions.

Strategic Partnerships Valeritas’ collaborations with organizations like Cecelia Health and partnerships with regional distributors highlight opportunities to build new strategic alliances, joint marketing efforts, and educational programs to drive adoption among healthcare providers and patients.

Acquisition and Growth Recent acquisition by Zealand Pharma with a focus on U.S. operations suggests potential for accelerated growth, new product development, and increased sales efforts in the diabetes care market, especially around innovative rescue and insulin delivery solutions.

Market Needs With a proven track record of lowering A1C levels and a focus on user-friendly, wearable technology, there are significant sales opportunities targeting endocrinologists, clinics, and health plans looking to enhance patient outcomes with effective, easy-to-use diabetes management devices.

Valeritas Tech Stack

Valeritas uses 8 technology products and services including SiteCatalyst, CIM Technologies, Google Fonts API, and more. Explore Valeritas's tech stack below.

  • SiteCatalyst
    Analytics
  • CIM Technologies
    Cad & Graphics
  • Google Fonts API
    Font Scripts
  • RequireJS
    Javascript Frameworks
  • Moment.js
    Javascript Libraries
  • New Relic
    Real User Monitoring
  • Google Analytics
    Web Analytics
  • AddThis
    Widgets

Media & News

Valeritas's Email Address Formats

Valeritas uses at least 1 format(s):
Valeritas Email FormatsExamplePercentage
FLast@valeritas.comJDoe@valeritas.com
49%
Last@valeritas.comDoe@valeritas.com
1%
FirstLast@valeritas.comJohnDoe@valeritas.com
1%
FLast@valeritas.comJDoe@valeritas.com
49%

Frequently Asked Questions

Where is Valeritas's headquarters located?

Minus sign iconPlus sign icon
Valeritas's main headquarters is located at 750 Route 202 South, Bridgewater, NJ 08807, US. The company has employees across 2 continents, including North AmericaEurope.

What is Valeritas's phone number?

Minus sign iconPlus sign icon
You can contact Valeritas's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Valeritas's stock symbol?

Minus sign iconPlus sign icon
Valeritas is a publicly traded company; the company's stock symbol is VLRXQ.

What is Valeritas's official website and social media links?

Minus sign iconPlus sign icon
Valeritas's official website is valeritas.com and has social profiles on LinkedInCrunchbase.

How much revenue does Valeritas generate?

Minus sign iconPlus sign icon
As of October 2025, Valeritas's annual revenue is estimated to be $993K.

What is Valeritas's NAICS code?

Minus sign iconPlus sign icon
Valeritas's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Valeritas have currently?

Minus sign iconPlus sign icon
As of October 2025, Valeritas has approximately 51 employees across 2 continents, including North AmericaEurope. Key team members include VP Regulatory Affairs & Quality Assurance: M. R.Owner Creative Director: J. E.Vp Quality And Regulatory: R. B.. Explore Valeritas's employee directory with LeadIQ.

What industry does Valeritas belong to?

Minus sign iconPlus sign icon
Valeritas operates in the Medical Equipment Manufacturing industry.

What technology does Valeritas use?

Minus sign iconPlus sign icon
Valeritas's tech stack includes SiteCatalystCIM TechnologiesGoogle Fonts APIRequireJSMoment.jsNew RelicGoogle AnalyticsAddThis.

What is Valeritas's email format?

Minus sign iconPlus sign icon
Valeritas's email format typically follows the pattern of FLast@valeritas.com. Find more Valeritas email formats with LeadIQ.

When was Valeritas founded?

Minus sign iconPlus sign icon
Valeritas was founded in 2006.
Valeritas

Valeritas

Medical Equipment ManufacturingUnited States51-200 Employees

We are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. We designed our first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, to help patients with Type 2 diabetes who require insulin to achieve and maintain their target blood glucose goals. 

V-Go is indicated for continuous subcutaneous infusion of insulin over 24 hours at preset rates and on-demand bolus dosing in two-unit increments in adult patients requiring insulin. V-Go is a small, discreet and easy-to-use disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. 

V-Go enables patients to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections.  V-Go enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin (fast-acting) at a continuous preset (background) basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. 

In numerous real-world analyses V-Go has consistently shown to lower A1C’s with less insulin. The discreet and convenient basal-bolus insulin delivery method provided by V-Go empowers patients to simplify their insulin management thereby mitigating the need to plan their daily routine around multiple daily injections. V-Go is cleared for use in the United States and the E.U. is commercially available in the United States.

Section iconCompany Overview

Headquarters
750 Route 202 South, Bridgewater, NJ 08807, US
Phone number
Stock Symbol
VLRXQ
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2006
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    Valeritas's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Valeritas's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.